In a syngeneic mouse model, with orthotopically implanted MB49 BC cell lines, treatment of mice with a PD-L1 inhibitor (Avelumab) led to a significant tumor reduction compared to BCG alone or a combination regimen [18]. The gene discussed is CD274; the disease is neoplasm.